CPPEI - Cardiovascular Prevention in Pre-Elderly and Elderly Individuals

Please see our recent practical recommendations dedicated for non-specialist on how to manage patients with lipid disorders! Very clear and easy to understand message! Thanks to and the team;-)

Hypercholesterolaemia – practical information for non-specialists Hypercholesterolaemia is amongst the most common conditions encountered in the medical profession. It remains one of the key modifiable cardiovascular risk factors and there have been recent advances in the risk stratification methods and treatment options available. In this review, we provide a...

The first recommendations on the lipid disorders therapy with nutraceuticals from the International Lipid Expert Panel (ILEP). It is a critical paper, which summarizes the current state of knowledge and indicates the nutraceuticals, which might have the greatest benefit in dyslipidemic patients and might be considered in: (1) primary prevention in individuals at the risk still not on the statin therapy; (2) in patients not on the lipid goal of the therapy as an add-on to statin therapy; (3) in patients with mixed dyslipidemia, including atherogenic dyslipidemia due to the influence of nutraceuticals on different lipid parameters, and finally (4) in patients with statin-associated side effects/statin intolerance. We also strongly emphasize that nutraceuticals cannot replace pharmacotherapy, and only help to optimize the therapy in order to achieve the LDL-C/lipid goals based on the risk stratification. Taking this opportunity I would like to thank to all European societies that endorsed the Position Paper as well as to all experts who have worked on this important paper. Special thanks to prof. Arrigo Cicero, who has initiated this idea. This paper will be published in parallel in Nutrition Reviews. Have a nice reading!

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

It was a wonderful 2nd CPPEI Congress in Vienna I had an occasion to Chair. Great sessions, discussions and opportunity to meet with friends and colleagues from all over the world. Some new ideas for joined projects. Very busy but also wonderful time! So the next - 3rd Congress in Cracow? Let you know asap ;-) Thanks for all and see you soon! Together with:

Only 3 Weeks Left to Register

Join us as we bringing together the leaders in the field of cardiology with a goal to:

• Showcase tangible innovations emerging from the cardiology field, including the latest research and development
• Engage in robust dialogue with knowledgeable speakers
• Include presentations from young upcoming specialists

The deadline to register for CPPEI 2017 is fast approaching - www.cardioelderly.org

Only 3 weeks left to register for CPPEI 2017! CPPEI 2017 Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals. Vienna, Austria, July 7-9, 2017.

Having chronically high blood pressure (hypertension) can eventually lead to problems like heart disease, which is one of the world’s most common causes of death. But according to a study at Oregon State University, elevated blood pressure was not found to be a high mortality risk for elderly individuals with a weak grip.

Register today and save up to €60 - www.cardioelderly.org

High blood pressure has minimal impact on mortality risk in elderly: Study Having chronically high blood pressure (hypertension) can eventually lead to problems like heart disease, which is one of the world’s most common causes of death. But according to a study at Oregon State University, elevated blood pressure was not found to be a high mortality risk for elderly indivi...

Today is World Hypertension Day – Know your numbers and increase high blood pressure awareness

World Hypertension Day The World Hypertension League is dedicated to the prevention and control of hypertension globally and comprised of national organizations that share resources to achieve our goals.

According to an article published in the World Journal on Cardiology: Hypertension in the elderly.

"The elderly are the most rapidly growing population group in the world. Data collected over a 30- year period have demonstrated the increasing prevalence of hypertension with age. The risk of coronary artery disease, stroke, congestive heart disease, chronic kidney insufficiency and dementia is also increased in this subgroup of hypertensives. Hypertension in the elderly patients represents a management dilemma to cardiovascular specialists and other practioners".

Register now and be part of the robust discussion on hypertension in elderly and the best treatment available.
www.cardioelderly.org

Have you submitted your abstract yet?

Only 6 days left to submit…. the clock is ticking.
Share your findings with knowledgeable industry leaders and colleagues at the CPPEI 2017 Congress.
www.cardioelderly.org

One of the most important papers in the field on the risk stratification (risks of bleeding and thrombosis) of ACS patients with CKD. Thanks to Adrian for this great initiative! It was a great pleasure to work in the group of the recognized experts in this field. Have a nice reading!

quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients | Nephrology Dialysis Transplantation | Oxford Academic

Important review from my research team. Have a nice reading!

Relationship Between Long non-coding RNAs and Physiological risk Factors of Cardiovascular Disease Long non-coding ribonucleic acids (lncRNAs) are an important category of non-coding RNAs that play crucial roles in controlling the expression of genes in health and in a range of illnesses including cardiovascular disease. A large body of genetic, experimental and epidemiological evidence suggests…

New meta-analysis from LBPMC Group on lipid-lowering effect of krill oil in humans. Another important contribution from my group in the nutrition/nutraceutical area. Have a nice reading! -;-)

Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials | Nutrition Reviews | Oxford Academic

Statin therapy increases the risk of new-onset diabetes in elderly women by 33%, and the higher the dose, the greater the risk, a new analysis of the observational Australian Longitudinal Study on Women's Health shows.
Read the full article here: http://wb.md/2nfBjiA

Join us in Vienna by submitting your abstract today: www.cardioelderly.org

Statins Increase Diabetes Risk by up to 50% in Older Women A new analysis homing in on elderly women finds increased risk of diabetes in users of statins vs nonusers and suggests doctors pay heed to careful risk/benefit assessment in this patient population.

What are the Guidelines on the Dyslipidemia Management in the Elderly?
Meet Prof. Alberico Catapano from the University of Milan at the 2nd Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals, July 7-9, 2017, Vienna, Austria. Do not miss out! Register now – www.cardioelderly.org

Here's your chance for a sneak preview of speakers for – 2nd Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals, July 7-9, 2017, Vienna, Austria.
Contribute your knowledge and expertise at . Submit your abstract today and a make a difference! www.cardioelderly.org

presents a great opportunity for interaction with your colleagues from many different countries. Present your research with us - www.cardioelderly.org

Registration is Now Open for the 2nd Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals

Secure your place and join us in Vienna, Austria
www.cardioelderly.org

Study Finds No Safety Concerns for Sitagliptin Use in Elderly Sitagliptin does not appear to increase the risk of cardiovascular events in patients with type 2 diabetes who are 75 years or older, according to results from the TECOS trial.

A review by clinical experts of the best available evidence concluded that cholesterol-lowering and blood pressure-controlling therapy are the most effective treatments for reducing cardiovascular events in older adults, but that treatment needs to be individualized, reports the Canadian Journal of Cardiology.

Submit your abstract today for and be part of the future of cardiovascular prevention in pre-elderly and elderly individuals.
www.cardioelderly.org

Older adults need better blood pressure and cholesterol control to prevent cardiovascular disease | Knowridge Science Report The leading cause of death in the elderly, the fastest growing segment of the population, is cardiovascular disease (CVD). Prevention of cardiovascular events in elderly patients presents a therapeutic challenge because this age group is generally underrepresented in clinical trials, and doctors oft...

Should the Prevention of CVD in the Elderly Begin Before We Get Old?

Submit your abstract for and share your work in front of hundreds of Physicians, Researchers and Key Opinion Leaders.
www.cardioelderly.org

CPPEI 2016, June 30 - July 2, 2016, Bratislava, Slovakia

Final Countdown to CPPEI 2016!
On-Site Registration will be available at € 500 on Thursday, 30 June at 16:00. See you in Bratislava, Slovakia
www.cardioelderly.org

Why is Depression in the Pre-Elderly and Elderly an Associated Risk of Cardiovascular Disease?
HURRY last days left to register: www.cardioelderly.org

Only two weeks until .
Plan ahead, mark down the sessions you want to join.
View the final program - http://www.cardioelderly.org/preliminary-program/

Why Should Prevention of CVD Begin before we are Elderly?
Register today for CPPEI and have the opportunity to engage in topics related to challenges in elderly and possible methods of prevention and treatment.
www.cardioelderly.org

We are delighted to announce that the 1st Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The Congress is designated for a maximum of, or up to 12 European CME credits.

Join us for this important gathering by registering today: www.cardioelderly.org

What is the Role of Micronutrients and Nutraceuticals in Chronic Heart Failure?
Register today – www.cardioelderly.org

The phenomenon of statin intolerance/statin-associated side effects is still a matter of high debate concerning its causality, pathomechanisms, possibilities of prediction with sensitve biomarkers, as well as suitable management. In this article we focused on the possible molecular mechanisms of statin intolerance. It is one of 6 papers from our group, which will be presented on this issue by the end of the year. Have a nice reading!

Molecular mechanisms of statin intolerance Statins reduce cardiovascular morbidity and mortality in primary and secondary prevention. Despite their efficacy, many persons are unable to tolerate statins due to adverse events such as hepatotoxicity and myalgia/myopathy. In the case of most patients, it seems that mild-to-moderate...